Header Logo

Connection

Summer Dewdney to Hydrazines

Back to Details
This is a "connection" page, showing publications Summer Dewdney has written about Hydrazines.
Summer Dewdney
Connection Strength
0.162
Hydrazines
  1. A phase II evaluation of elesclomol sodium and weekly paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube or primary peritoneal cancer: An NRG oncology/gynecologic oncology group study. Gynecol Oncol. 2018 12; 151(3):422-427.
    View in: PubMed
    Score: 0.162
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.